Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer
Madoka Iwase, Masashi Ando, Kenjiro Aogi, Tomoyuki Aruga, Kenichi Inoue, Akihiko Shimomura, Eriko Tokunaga, Norikazu Masuda, Hideko Yamauchi, Toshinari Yamashita, Hiroji Iwata
Topics & Concepts
CarboplatinMedicineEpirubicinBreast cancerInternal medicineChemotherapyOncologyTriple-negative breast cancerClinical endpointPopulationPaclitaxelCancerGastroenterologyRandomized controlled trialCisplatinEnvironmental healthBreast Cancer Treatment StudiesCancer Treatment and PharmacologyBreast Lesions and Carcinomas